Your shopping cart is currently empty

Salixteroside D is a derivative of salicin, exhibiting anti-inflammatory properties by inhibiting the MAPK and NF-κB signaling pathways.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Salixteroside D is a derivative of salicin, exhibiting anti-inflammatory properties by inhibiting the MAPK and NF-κB signaling pathways. |
| In vitro | Salixteroside D, at a concentration of 20 μM for 24 hours, inhibits the production of NO in RAW 264.7 cells with an IC50 of 6.75 μM, and exhibits no toxicity to RAW 264.7 cells. Additionally, Salixteroside D at concentrations ranging from 5-20 μM for 12 hours suppresses the expression of inflammatory mediators IL-1β, IL-6, iNOS, and COX-2 in Lipopolysaccharides-induced RAW 264.7 macrophages. |
| Formula | C22H26O11 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.